Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis.

RD, Hull; GE, Raskob; GF, Pineo; D, Green; AA, Trowbridge; CG, Elliott; RG, Lerner; J, Hall; T, Sparling; HR, Brettell

doi:10.1056/nejm199204093261502

Public

Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis.

Shared by NobleBlocks on Apr 1, 1992 • 12:00 AM UTC

Authors:

Hull RD

Raskob GE

Pineo GF

Abstract

Background Low-molecular-weight heparin has a high bioavailability and a prolonged half-life in comparison with conventional unfractionated heparin. Limited data are available for low-molecular-weight heparin as compared with unfractionated heparin for the treatment of deep-vein thrombosis.Methods I...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!